模拟大麻的药理动力学和肝毒性方面的进展和挑战
Jessica L Beers1, Zhu Zhou2, Klarissa D Jackson2
1Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (J.L.B., K.D.J.); and Department of Chemistry, York College, City University of New York, Jamaica, New York (Z.Z.) jlbeers@uw.edu.
大麻素 (CBD) 是FDA批准的药物,可导致肝损伤,特别是酸. 了解CBD的药理动力学和毒性机制对于公共卫生和安全使用至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 大麻治疗药物 大麻治疗药物
背景情况:
- 大麻 (CBD) 是FDA批准用于特定的儿童.
- CBD可以引起剂量依赖的肝毒性,特别是在与酸联合使用时.
- 消费者越来越多地使用CBD,因此需要更好地了解其安全性.
研究的目的:
- 审查关于CBD药理动力学和肝毒性机制的当前知识.
- 为了识别了解CBD诱导的肝损伤的知识差距.
- 建议未来的研究方向,结合建模和生物标志物.
主要方法:
- 对CBD代谢和药理动力学现有的临床前数据的审查.
- 对体外肝脏模型进行分析,以研究CBD诱导的毒性.
- 对药物动力学建模方法的讨论.
主要成果:
- 在治疗水平上,CBD呈现剂量依赖的肝细胞毒性.
- 与氨酸的同时使用可能会增加CBD诱导的肝损伤的风险.
- 目前对CBD肝毒性的细胞内机制的理解仍然不完整.
结论:
- 需要进一步的研究来阐明CBD的药理动力学和毒性关系.
- 基于系统的模型与毒性标记器相结合,可以提高对CBD安全性的理解.
- 准确的药理动力学建模对于预测和管理CBD诱导的肝损伤至关重要.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...


